Hilde Geurts is professor of clinical neuropsychology at the University of Amsterdam in the Netherlands and senior researcher in the autism clinic of Leo Kannerhuis.
Hilde Geurts
Professor
University of Amsterdam
From this contributor
Validating autism subtypes: A crucial but often overlooked step in research
Studies of autism subtypes rarely validate their results, and this has led to a proliferation of autism subtypes of questionable utility. But reliable subtyping can help improve the prognosis for and care of autistic people.
Validating autism subtypes: A crucial but often overlooked step in research
By
Hilde Geurts, Joost Agelink van Rentergem
31 August 2021 | 5 min read
Explore more from The Transmitter
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
By
Ashley Juavinett
30 March 2026 | 8 min read
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
By
Dalmeet Singh Chawla
27 March 2026 | 5 min read
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.
By
Claudia López Lloreda
26 March 2026 | 4 min read